MY ACCOUNT | NEWSLETTER |

Tumor incidence in dogs in Germany


Characterization of a tumor entity is based on the precise histopathological diagnosis considering the signalment of the diseased animal. The present study is a comprehensive, up-to-date statistical investigation on the type, frequency and breed distribution of neoplasia in dogs in Germany.  

The histopathological datasets of 109,616 German canine tissue samples (2014-2019) were processed and statistically examined in retrospect. Non-neoplastic diseases were found in 38,650 samples (35.3%) and 70,966 neoplasms (64.7%) were diagnosed. The most common neoplasms were mammary tumors (21.9%), benign epithelial skin tumors (15.4%), mast cell tumor (9.7%), histiocytoma (7.0%), soft tissue sarcoma (5.8%), lipoma (5.8%), melanocytic tumors (5.2%) and odontogenic tumors (4.7%). In general, beagles, Magyar vizslas, boxers, schnauzers, spaniels, French bulldogs and golden retrievers had an increased risk of neoplasia (odds ratio 1.17-1.46; all: P ≤0.001) compared with crossbreed dogs.

Boxers, golden retrievers, rottweilers and schnauzers were often affected by malignant neoplasms, whereas some breeds — West Highland white terrier, Magyar vizsla, chihuahua, dachshund and Yorkshire terrier — were frequently affected by numerous benign tumor types. Despite the known risk of hemangiosarcoma in German Shepherd Dogs, other malignant tumors were rare in this breed.  

Depending on the type of tumor, some purebred dog breeds can have an increased, reduced or identical risk for certain neoplasms compared with crossbreeds. In conclusion, discussion of breed predispositions to tumor diseases must therefore be conducted critically and with a view to clinical relevance.

Heike Aupperle-Lellbach, et al. “Tumour Incidence in Dogs in Germany: a Retrospective Analysis of 109,616 Histopathological Diagnoses (2014-2019).” J Comp Pathol. 2022 Sep 2;198:33-55.  doi: 10.1016/j.jcpa.2022.07.009.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Innovations in animal health: artificial intelligence-enhanced hematocrit analysis for rapid anemia detection in small ruminants

Like0
Dislike0

Drug dose and drug choice: Optimizing medical therapy for veterinary cancer

Like0
Dislike0

The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients

Like0
Dislike0

NC State Student Creates Coloring Book to Help Children Picture Possibilities in Veterinary Medicine

Like0
Dislike0

UltiMed Expands Syringe Portfolio with Launch of UltiCare® VetRx General Syringes

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top